BioTech Mag Search: Therapeutics
Analysts ponder what Sarepta's whirlwind approval means for Biogen-are all bets off?
After being hit with an FDA rejection for Sarepta Therapeutics' second Duchenne muscular dystrophy drug back in the summer, it looked like a long road, tinged with more than a...
10 minutes ago - Fierce Biotech
Mirati Therapeutics: Head of Medical Affairs
Mirati Therapeutics: The Head of Medical Affairs will be responsible for building a US Medical Affairs organization and developing strategic and tactical plans to support San...
3 hours ago - San Diego Biotechnology - 4 articles
Mirati Therapeutics: Principal Statistical Programmer
Mirati Therapeutics: As Principal Statistical Programmer, you will lead programming support for oncology development program in multiple stages of clinical development. Th San...
3 hours ago - San Diego Biotechnology - 2 articles
Mirati Therapeutics: Safety Scientist
Mirati Therapeutics: Mirati is looking for a Safety Scientist to join our growing team. This position is responsible for global safety assessment of investigational and ma San...
3 hours ago - San Diego Biotechnology - 4 articles
Mirati Therapeutics: Sr. Associate Scientist, Protein Chemistry
Mirati Therapeutics: Mirati is seeking a protein chemist with a track record of generating high-quality recombinant protein for use in structural biology, biochemistry, bi San...
3 hours ago - San Diego Biotechnology - 4 articles
Mirati Therapeutics: Synthetic Organic Chemist
Mirati Therapeutics: Mirati is seeking extraordinary synthetic organic chemists to join the Drug Discovery group at the associate scientist level and above. You have broa San...
3 hours ago - San Diego Biotechnology - 4 articles
Oncternal Therapeutics Announces Presentation of Interim Clinical Data on Cirmtuzumab in Combination with Paclitaxel at 2019 San Antonio Breast Cancer Symposium
SAN DIEGO--Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the presentation of...
13 hours ago - San Diego Biotechnology
MiRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
MicroRNA therapies developer miRagen Therapeutics is scaling back work on its most advanced cancer drug candidate and shifting resources to a compound being developed to treat...
15 hours ago - Xconomy
Quality Control Microbiology Associate - Sorrento Therapeutics - San Diego, CA
Maintain the QC Microbiology laboratory including ordering materials, inventory control and general lab housekeeping while sustaining safety standards.From Sorrento...
20 hours ago - San Diego Biotechnology - 2 articles
ClinVAP: A reporting strategy from variants to therapeutic options
AbstractMotivationNext-generation sequencing has become routine in oncology and opens up new avenues of therapies, particularly in personalized oncology setting. An increasing...
22 hours ago - Oxford Journals
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
MiRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
MicroRNA therapies developer miRagen Therapeutics is scaling back work on its most advanced cancer drug candidate and shifting resources to a compound being developed to treat...
Tiny Quantum Sensors Watch Materials Transform Under Pressure
At left, natural diamonds glow under ultraviolet light owing to their various nitrogen-vacancy centers. At right, a schematic depicting the diamond anvils in action, with NV...
Simulations Attempt to Reconstruct One of the Most Explosive Events in the...
Artist's illustration of two merging neutron stars. The rippling space-time grid represents gravitational waves that travel out from the collision, while the narrow beams show...
Amgen's Osteoporosis Drug Wins European Nod, With a Heart Warning
An osteoporosis drug developed by Amgen now has marketing approval in Europe, but it carries a warning that the medicine can raise the risk of cardiovascular problems...
Aspen Neuro Bags $6.5M to Test Parkinson's Disease Stem Cell Therapy
Nearly nine years ago Jeanne Loring and her colleagues at Scripps Research debuted a test that leveraged advances in genomics and data science to determine, without testing in...
How Thermo Fisher Scientific Streamlined Inspection Management With AuditUtopia®
Case Study Overview In highly regulated industries, you can count on the fact that your company will be inspected a time or two by regulatory agencies and/or your clients. Most...
Cover Picture: Biotechnology Journal 12/2019
Microbial poly‐3‐hydroxybutyrate has been produced via microbial fermentation and safely used as feed additives for sea based large yellow croakers and sensitive land based...
Iterum's Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink
Iterum Therapeutics' bid to bring patients a new antibiotic that's safer than currently available drugs has fallen short of the main efficacy goal of a late-stage clinical...
A Peek into the Battery Technology Pipeline
Berkeley Lab battery researcher Gerbrand Ceder Lithium ion is probably the most advanced technology available for the packs of rechargeable batteries you'll buy this holiday...
Long-Read Sequencing Could Improve the Sensitivity and Precision of 16S...
It's time to revisit the way scientists are using 16S rRNA gene sequencing to study microorganisms, according to a team of Jackson Laboratory researchers. Popular targets for...